142 related articles for article (PubMed ID: 3201650)
1. Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r.
Hansenson M; Lundh B; Hartley-Asp B; Pousette A
Urol Res; 1988; 16(5):357-61. PubMed ID: 3201650
[TBL] [Abstract][Full Text] [Related]
2. Difference in uptake of 3H-estramustine in two human prostatic carcinoma cell lines, LNCaP and LNCaP-r.
Hasenson M
Urol Res; 1989; 17(2):103-6. PubMed ID: 2734976
[TBL] [Abstract][Full Text] [Related]
3. Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).
Hartley-Asp B; Gunnarsson PO
J Urol; 1982 Apr; 127(4):818-22. PubMed ID: 7069864
[TBL] [Abstract][Full Text] [Related]
4. Effects of estramustine and its constituents on human malignant glioma cells.
von Schoultz E; Lundgren E; Henriksson R
Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
[TBL] [Abstract][Full Text] [Related]
5. Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research.
Pousette A; Carlström K; Henriksson P; Grande M; Stege R
Prostate; 1997 May; 31(3):198-203. PubMed ID: 9167773
[TBL] [Abstract][Full Text] [Related]
6. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Wang LG; Liu XM; Kreis W; Budman DR
Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
[TBL] [Abstract][Full Text] [Related]
7. A study on the effects of estradiol and estramustine on gastrointestinal cell lines.
Harrison JD; Watson S; Ellis IO; Morris DL
Eur J Surg Oncol; 1990 Apr; 16(2):116-20. PubMed ID: 2182340
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
9. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
Stearns ME; Tew KD
Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
[TBL] [Abstract][Full Text] [Related]
10. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line.
Kirschenbaum A; Ren M; Levine AC
Steroids; 1993 Sep; 58(9):439-44. PubMed ID: 8236330
[TBL] [Abstract][Full Text] [Related]
11. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
von Schoultz E; Lundblad D; Bergh J; Grankvist K; Henriksson R
Br J Cancer; 1988 Sep; 58(3):326-9. PubMed ID: 3052561
[TBL] [Abstract][Full Text] [Related]
12. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
13. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
[TBL] [Abstract][Full Text] [Related]
14. Nuclear protein matrix as a target for estramustine-induced cell death.
Hartley-Asp B; Kruse E
Prostate; 1986; 9(4):387-95. PubMed ID: 3786258
[TBL] [Abstract][Full Text] [Related]
15. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
Essand M; Nilsson S; Carlsson J
Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
Nilsson I; Liskowski L; Nilsson T
Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
[TBL] [Abstract][Full Text] [Related]
17. The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane.
Henriksson R; Bjermer L; Von Schoultz E; Grankvist K
Anticancer Res; 1990; 10(2A):303-9. PubMed ID: 2346305
[TBL] [Abstract][Full Text] [Related]
18. Autocrine effect of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCAP: role of interleukin-6.
Okamoto M; Lee C; Oyasu R
Endocrinology; 1997 Nov; 138(11):5071-4. PubMed ID: 9348243
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75-1 cells.
de Launoit Y; Dauvois S; Dufour M; Simard J; Labrie F
Cancer Res; 1991 Jun; 51(11):2797-802. PubMed ID: 2032219
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.
de Launoit Y; Veilleux R; Dufour M; Simard J; Labrie F
Cancer Res; 1991 Oct; 51(19):5165-70. PubMed ID: 1913642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
